Naoto Hirano Department of Immunology University of Toronto Biography Publications Institution JoVE Articles Naoto Hirano has not added a biography. If you are Naoto Hirano and would like to personalize this page please email our Author Liaison for assistance. Publications BET Bromodomain Inhibition Enhances T Cell Persistence and Function in Adoptive Immunotherapy Models The Journal of Clinical Investigation. Sep, 2016 | Pubmed ID: 27548527 Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors PloS One. 2016 | Pubmed ID: 27213277 CD4(+) and CD8(+) TCRβ Repertoires Possess Different Potentials to Generate Extraordinarily High-avidity T Cells Scientific Reports. Mar, 2016 | Pubmed ID: 27030642 CDR3β Sequence Motifs Regulate Autoreactivity of Human Invariant NKT Cell Receptors Journal of Autoimmunity. Apr, 2016 | Pubmed ID: 26748722 Adoptive T Cell Therapy Targeting CD1 and MR1 Frontiers in Immunology. 2015 | Pubmed ID: 26052329 Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy Cancer Immunology Research. Sep, 2015 | Pubmed ID: 25943533 Specific Roles of Each TCR Hemichain in Generating Functional Chain-centric TCR Journal of Immunology (Baltimore, Md. : 1950). Apr, 2015 | Pubmed ID: 25710913 Human Cell-based Artificial Antigen-presenting Cells for Cancer Immunotherapy Immunological Reviews. Jan, 2014 | Pubmed ID: 24329798 Ex Vivo Expansión De Células CD8 T Humanas Utilizando Células CD4 T Autólogas Ayuda PloS One. 2012 | Pubmed ID: 22279573 IL-21 Puede Complementar La Activación De MAPK Subóptima De Lck-independiente En Forma De STAT-3-dependiente En Las Células Humanas CD8 + T Journal of Immunology (Baltimore, Md. : 1950). Feb, 2012 | Pubmed ID: 22238455 [The Cutting Edge of Antitumor Adoptive Cell Therapy] [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology. Oct, 2011 | Pubmed ID: 21971251 Inducción De Restricción HLA-DP4 Anti-survivin Th1 Y Th2 Respuestas Usando Una Célula Presentadora De Antígeno Artificial Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2011 | Pubmed ID: 21705450 The Third Consensus Conference on the Treatment of Aplastic Anemia International Journal of Hematology. Jun, 2011 | Pubmed ID: 21617886 Establecimiento De Memoria Antitumoral En Los Seres Humanos En Educado En Vitro De Células T CD8 + Science Translational Medicine. Apr, 2011 | Pubmed ID: 21525398 A Panel of Human Cell-based Artificial APC Enables the Expansion of Long-lived Antigen-specific CD4+ T Cells Restricted by Prevalent HLA-DR Alleles International Immunology. Nov, 2010 | Pubmed ID: 21059769 Juvenile Myelomonocytic Leukemia: Epidemiology, Etiopathogenesis, Diagnosis, and Management Considerations Paediatric Drugs. 2010 | Pubmed ID: 20034338 Disociación De Sus Efectos Inmunológicos Oposición Es Crítica Para La Optimización De Las Respuestas De Células T CD8 + Antitumorales Inducida Por Interleucina 21 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2008 | Pubmed ID: 18829491 Clinical Impact of HLA-DR15, a Minor Population of Paroxysmal Nocturnal Haemoglobinuria-type Cells, and an Aplastic Anaemia-associated Autoantibody in Children with Acquired Aplastic Anaemia British Journal of Haematology. Jul, 2008 | Pubmed ID: 18537977 Larga Vida Antitumorales CD8 + Linfocitos Para Terapia Adoptiva Generados Utilizando Una Célula Presentadora De Antígeno Artificial Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2007 | Pubmed ID: 17363542 Volcanism in Response to Plate Flexure Science (New York, N.Y.). Sep, 2006 | Pubmed ID: 16873612 Identificación De Un Epitopo De Células T CD8 + Inmunogénico Deriva De Gamma-globina, Un Supuesta Antígeno Tumor Para La Leucemia Mielomonocítica Juvenil Blood. Oct, 2006 | Pubmed ID: 16778141 Presentación Eficiente De Procesados Naturalmente HLA Clase I Péptidos Por Células Presentadoras De Antígeno Artificiales Para La Generación De Respuestas Antitumorales Efectivas Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2006 | Pubmed ID: 16707591 La Participación De CD83 Ligando Induce La Prolongada Expansión De Células T CD8 + Y El Enriquecimiento Preferencial Para El Antígeno Específico Blood. Feb, 2006 | Pubmed ID: 16239433 The Chemical Structure of the Hawaiian Mantle Plume Nature. Aug, 2005 | Pubmed ID: 16100780 La Presencia De Anticuerpos Anti-kinectin Y Anti PMS1 En Pacientes Japoneses Con Anemia Aplásica British Journal of Haematology. Jan, 2005 | Pubmed ID: 15638857 Autoanticuerpos Más Frecuentes Detectados En Los Pacientes Con Anemia Aplásica Blood. Dec, 2003 | Pubmed ID: 12947009 La Compartido Antígeno Asociado Al Tumor Del Citocromo P450 1B1 Es Reconocido Por Células T Citotóxicas Específicas Blood. Nov, 2003 | Pubmed ID: 12869499 Humanos Respuestas Citotóxicas De Primaria Y Los Linfocitos T De Memoria De Manera Eficiente Inducida Por Medio De Células B CD40-activados Como Células Presentadoras De Antígeno: Potencial Para La Aplicación Clínica Blood. May, 2002 | Pubmed ID: 11964299 Generando Tingxi Guo1,2, Toshiki Ochi*2, Munehide Nakatsugawa*2, Yuki Kagoya2, Mark Anczurowski1,2, Chung-Hsi Wang1,2, Muhammed A. Rahman2, Kayoko Saso2, Marcus O. Butler1,2, Naoto Hirano1,2 1Department of Immunology, University of Toronto, 2Princess Margaret Cancer Centre, University Health Network JoVE 54697 Imunologia e Infecção
Generando Tingxi Guo1,2, Toshiki Ochi*2, Munehide Nakatsugawa*2, Yuki Kagoya2, Mark Anczurowski1,2, Chung-Hsi Wang1,2, Muhammed A. Rahman2, Kayoko Saso2, Marcus O. Butler1,2, Naoto Hirano1,2 1Department of Immunology, University of Toronto, 2Princess Margaret Cancer Centre, University Health Network JoVE 54697 Imunologia e Infecção